首頁 > 市場調查報告書 > 製藥

癌症生物標記

市場調查報告書

商品編碼

1370428

癌症生物標記市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Cancer Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: 2023年10月15日 | 出版商:

IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

概要

市場概況：

2022年，全球癌症生物標記市場規模達到247億美元。展望未來，IMARC Group預計到2028年市場規模將達到537億美元，2023-2028年年複合成長率（CAGR）為12.95%。

癌症生物標記是指血液、組織或身體其他液體中存在癌細胞的生物分子。它們可以由癌細胞本身或體內其他組織對癌症的反應產生。一些常見的癌症包括乳癌、攝護腺癌、子宮頸癌、肺癌和大腸癌。它們廣泛用於診斷疾病、監測其進展、區分侵襲性和非侵襲性腫瘤、預測復發機會和記錄治療效果。酵素、蛋白質、核酸、基因、特定細胞。和勝肽是一些常見的生物標記類型。因此，它們被廣泛用作預後、替代終點、診斷和個人化藥物。

癌症生物標記市場趨勢：

全球癌症盛行率不斷上升，為市場創造了積極的前景。生物標記廣泛用於早期癌症檢測以及治療和管理過程中，以準確可靠地預測結果。與此一致的是，由於污染水平上升、吸煙趨勢和不良飲食習慣導致肺癌發病率不斷增加，從而促進了市場的成長。此外，遺傳生物標記發現的各種技術進步，例如次世代定序（NGS）、聚合酶鍊式反應（PCR）、基因表現譜（微陣列）和人工不雅（AI）有助於預測癌症復發後的復發。治療，正在為市場成長提供動力。此外，醫療保健專業人員和患者對早期診斷重要性的認知不斷提高，以及由於缺乏標準診斷而導致癌症治療向個人化醫療的重大轉變，有利於市場成長。其他因素，包括醫療保健行業的顯著成長、廣泛的研發（R＆D）活動以及加強藥物開發流程的各種政府舉措的實施，預計將推動市場成長。

本報告回答的關鍵問題

2022 年全球癌症生物標記市場規模有多大？
2023-2028年全球癌症生物標記市場的預期成長率是多少？
推動全球癌症生物標記市場的關鍵因素是什麼？
COVID-19 對全球癌症生物標記市場有何影響？
基於生物分子的全球癌症生物標記市場的詳細情形如何？
根據癌症類型，全球癌症生物標記市場的詳細情形如何？
全球癌症生物標記市場的關鍵區域有哪些？
誰是全球癌症生物標記市場的主要參與者/公司？

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 按國家/地區分類的市場細分
- 市場預測

第 12 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 13 章：價值鏈分析

第 14 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 15 章：價格分析

第16章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- Abbott Laboratories
- Agilent Technologies Inc.
- Becton Dickinson and Company
- bioMerieux SA
- Danaher Corporation
- F. Hoffmann-La Roche AG
- General Electric Company
- Illumina Inc.
- Qiagen NV
- Sino Biological Inc.
- Thermo Fisher Scientific Inc.

簡介目錄圖表

Product Code: SR112023A5834

Abstract

Market Overview:

The global cancer biomarkers market size reached US$ 24.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 53.7 Billion by 2028, exhibiting a growth rate (CAGR) of 12.95% during 2023-2028.

Cancer biomarkers are biological molecules that indicate the presence of cancerous cells in the blood, tissues or other fluids of the body. They can be produced by the cancer cell itself or by other tissues in the body in response to cancer. Some common forms of cancer include breast, prostate, cervical, lung, and colorectal cancer. They are widely used for diagnosing the disease, monitoring their progression, distinguishing between invasive and non-invasive tumors, predicting the chances of recurrences and recording therapeutic treatment efficacy. Enzymes, proteins, nucleic acids, genes, specific cells. and peptides are some of the common types of biomarkers. As a result, they are widely used as prognostics, surrogate endpoints, diagnostics, and personalized medicines.

Cancer Biomarkers Market Trends:

The increasing prevalence of cancer across the globe is creating a positive outlook for the market. Biomarkers are widely used for early cancer detection and during treatment and management to accurately and reliably predict outcomes. In line with this, the increasing incidences of lung cancer due to the upsurge in pollution levels, smoking trends and poor ingestion habits is augmenting the market growth. Moreover, various technological advancements in genetic biomarker discovery, such as next-generation sequencing (NGS), polymerase chain reaction (PCR), gene expression profiling (microarray), and the artificial inelegance (AI) that assist in predicting the recurrence of cancer after treatment, are providing an impetus to the market growth. Additionally, the increasing awareness amongst healthcare professionals and patients about the importance of early diagnosis and the significant shift toward personalized medicine for cancer treatment due to the lack of standard diagnosis is favoring the market growth. Other factors, including the significant growth in the healthcare industry, extensive research and development (R&D) activities and the implementation of various government initiatives for enhancing the drug development processes, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cancer biomarkers market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on profiling technology, biomolecule, cancer type, application and end user.

Breakup by Profiling Technology:

Omic Technologies

Imaging Technologies

Immunoassays

Cytogenetics

Breakup by Biomolecule:

Genetic Biomarkers

Protein Biomarkers

Glyco-Biomarkers

Breakup by Cancer Type:

Breast Cancer

Lung Cancer

Colorectal Cancer

Prostate Cancer

Stomach Cancer

Others

Breakup by Application:

Diagnostics

Prognostics

Risk Assessment

Drug Discovery and Development

Others

Breakup by End User:

Hospitals

Academic and Research Institutions

Ambulatory Surgical Centers

Diagnostic Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, bioMerieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, General Electric Company, Illumina Inc., Qiagen N.V., Sino Biological Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

1. What was the size of the global cancer biomarkers market in 2022?
2. What is the expected growth rate of the global cancer biomarkers market during 2023-2028?
3. What are the key factors driving the global cancer biomarkers market?
4. What has been the impact of COVID-19 on the global cancer biomarkers market?
5. What is the breakup of the global cancer biomarkers market based on the biomolecule?
6. What is the breakup of the global cancer biomarkers market based on the cancer type?
7. What are the key regions in the global cancer biomarkers market?
8. Who are the key players/companies in the global cancer biomarkers market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Cancer Biomarkers Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Profiling Technology

6.1 Omic Technologies
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Imaging Technologies
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Immunoassays
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Cytogenetics
- 6.4.1 Market Trends
- 6.4.2 Market Forecast

7 Market Breakup by Biomolecule

7.1 Genetic Biomarkers
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Protein Biomarkers
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Glyco-Biomarkers
- 7.3.1 Market Trends
- 7.3.2 Market Forecast

8 Market Breakup by Cancer Type

8.1 Breast Cancer
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Lung Cancer
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Colorectal Cancer
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Prostate Cancer
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Stomach Cancer
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
8.6 Others
- 8.6.1 Market Trends
- 8.6.2 Market Forecast

9 Market Breakup by Application

9.1 Diagnostics
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Prognostics
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Risk Assessment
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Drug Discovery and Development
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
9.5 Others
- 9.5.1 Market Trends
- 9.5.2 Market Forecast

10 Market Breakup by End User

10.1 Hospitals
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
10.2 Academic and Research Institutions
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
10.3 Ambulatory Surgical Centers
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
10.4 Diagnostic Laboratories
- 10.4.1 Market Trends
- 10.4.2 Market Forecast
10.5 Others
- 10.5.1 Market Trends
- 10.5.2 Market Forecast

11 Market Breakup by Region

11.1 North America
- 11.1.1 United States
  - 11.1.1.1 Market Trends
  - 11.1.1.2 Market Forecast
- 11.1.2 Canada
  - 11.1.2.1 Market Trends
  - 11.1.2.2 Market Forecast
11.2 Asia-Pacific
- 11.2.1 China
  - 11.2.1.1 Market Trends
  - 11.2.1.2 Market Forecast
- 11.2.2 Japan
  - 11.2.2.1 Market Trends
  - 11.2.2.2 Market Forecast
- 11.2.3 India
  - 11.2.3.1 Market Trends
  - 11.2.3.2 Market Forecast
- 11.2.4 South Korea
  - 11.2.4.1 Market Trends
  - 11.2.4.2 Market Forecast
- 11.2.5 Australia
  - 11.2.5.1 Market Trends
  - 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
  - 11.2.6.1 Market Trends
  - 11.2.6.2 Market Forecast
- 11.2.7 Others
  - 11.2.7.1 Market Trends
  - 11.2.7.2 Market Forecast
11.3 Europe
- 11.3.1 Germany
  - 11.3.1.1 Market Trends
  - 11.3.1.2 Market Forecast
- 11.3.2 France
  - 11.3.2.1 Market Trends
  - 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
  - 11.3.3.1 Market Trends
  - 11.3.3.2 Market Forecast
- 11.3.4 Italy
  - 11.3.4.1 Market Trends
  - 11.3.4.2 Market Forecast
- 11.3.5 Spain
  - 11.3.5.1 Market Trends
  - 11.3.5.2 Market Forecast
- 11.3.6 Russia
  - 11.3.6.1 Market Trends
  - 11.3.6.2 Market Forecast
- 11.3.7 Others
  - 11.3.7.1 Market Trends
  - 11.3.7.2 Market Forecast
11.4 Latin America
- 11.4.1 Brazil
  - 11.4.1.1 Market Trends
  - 11.4.1.2 Market Forecast
- 11.4.2 Mexico
  - 11.4.2.1 Market Trends
  - 11.4.2.2 Market Forecast
- 11.4.3 Others
  - 11.4.3.1 Market Trends
  - 11.4.3.2 Market Forecast
11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast

12 SWOT Analysis

12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
- 16.3.1 Abbott Laboratories
  - 16.3.1.1 Company Overview
  - 16.3.1.2 Product Portfolio
  - 16.3.1.3 Financials
  - 16.3.1.4 SWOT Analysis
- 16.3.2 Agilent Technologies Inc.
  - 16.3.2.1 Company Overview
  - 16.3.2.2 Product Portfolio
  - 16.3.2.3 Financials
  - 16.3.2.4 SWOT Analysis
- 16.3.3 Becton Dickinson and Company
  - 16.3.3.1 Company Overview
  - 16.3.3.2 Product Portfolio
  - 16.3.3.3 Financials
  - 16.3.3.4 SWOT Analysis
- 16.3.4 bioMerieux SA
  - 16.3.4.1 Company Overview
  - 16.3.4.2 Product Portfolio
  - 16.3.4.3 Financials
  - 16.3.4.4 SWOT Analysis
- 16.3.5 Danaher Corporation
  - 16.3.5.1 Company Overview
  - 16.3.5.2 Product Portfolio
  - 16.3.5.3 Financials
  - 16.3.5.4 SWOT Analysis
- 16.3.6 F. Hoffmann-La Roche AG
  - 16.3.6.1 Company Overview
  - 16.3.6.2 Product Portfolio
  - 16.3.6.3 SWOT Analysis
- 16.3.7 General Electric Company
  - 16.3.7.1 Company Overview
  - 16.3.7.2 Product Portfolio
  - 16.3.7.3 Financials
  - 16.3.7.4 SWOT Analysis
- 16.3.8 Illumina Inc.
  - 16.3.8.1 Company Overview
  - 16.3.8.2 Product Portfolio
  - 16.3.8.3 Financials
  - 16.3.8.4 SWOT Analysis
- 16.3.9 Qiagen N.V.
  - 16.3.9.1 Company Overview
  - 16.3.9.2 Product Portfolio
  - 16.3.9.3 Financials
  - 16.3.9.4 SWOT Analysis
- 16.3.10 Sino Biological Inc.
  - 16.3.10.1 Company Overview
  - 16.3.10.2 Product Portfolio
- 16.3.11 Thermo Fisher Scientific Inc.
  - 16.3.11.1 Company Overview
  - 16.3.11.2 Product Portfolio
  - 16.3.11.3 Financials
  - 16.3.11.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Cancer Biomarkers Market: Major Drivers and Challenges
Figure 2: Global: Cancer Biomarkers Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Cancer Biomarkers Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Cancer Biomarkers Market: Breakup by Profiling Technology (in %), 2022
Figure 5: Global: Cancer Biomarkers Market: Breakup by Biomolecule (in %), 2022
Figure 6: Global: Cancer Biomarkers Market: Breakup by Cancer Type (in %), 2022
Figure 7: Global: Cancer Biomarkers Market: Breakup by Application (in %), 2022
Figure 8: Global: Cancer Biomarkers Market: Breakup by End User (in %), 2022
Figure 9: Global: Cancer Biomarkers Market: Breakup by Region (in %), 2022
Figure 10: Global: Cancer Biomarkers (Omic Technologies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Cancer Biomarkers (Omic Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Cancer Biomarkers (Imaging Technologies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Cancer Biomarkers (Imaging Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Cancer Biomarkers (Immunoassays) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Cancer Biomarkers (Immunoassays) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Cancer Biomarkers (Cytogenetics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Cancer Biomarkers (Cytogenetics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Cancer Biomarkers (Genetic Biomarkers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Cancer Biomarkers (Genetic Biomarkers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Cancer Biomarkers (Protein Biomarkers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Cancer Biomarkers (Protein Biomarkers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Cancer Biomarkers (Glyco-Biomarkers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Cancer Biomarkers (Glyco-Biomarkers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Cancer Biomarkers (Breast Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Cancer Biomarkers (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Cancer Biomarkers (Lung Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Cancer Biomarkers (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Cancer Biomarkers (Colorectal Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Cancer Biomarkers (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Cancer Biomarkers (Prostate Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Cancer Biomarkers (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Cancer Biomarkers (Stomach Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Cancer Biomarkers (Stomach Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Cancer Biomarkers (Other Cancer Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Cancer Biomarkers (Other Cancer Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Cancer Biomarkers (Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Cancer Biomarkers (Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Global: Cancer Biomarkers (Prognostics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Global: Cancer Biomarkers (Prognostics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Global: Cancer Biomarkers (Risk Assessment) Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Global: Cancer Biomarkers (Risk Assessment) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Global: Cancer Biomarkers (Drug Discovery and Development) Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Global: Cancer Biomarkers (Drug Discovery and Development) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Global: Cancer Biomarkers (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Global: Cancer Biomarkers (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Global: Cancer Biomarkers (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Global: Cancer Biomarkers (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Global: Cancer Biomarkers (Academic and Research Institutions) Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Global: Cancer Biomarkers (Academic and Research Institutions) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Global: Cancer Biomarkers (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Global: Cancer Biomarkers (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Global: Cancer Biomarkers (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Global: Cancer Biomarkers (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Global: Cancer Biomarkers (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Global: Cancer Biomarkers (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: North America: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: North America: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: United States: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: United States: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Canada: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Canada: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Asia-Pacific: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Asia-Pacific: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: China: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: China: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Japan: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Japan: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: India: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: India: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: South Korea: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: South Korea: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Australia: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Australia: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Indonesia: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Indonesia: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Others: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Others: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Europe: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Europe: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Germany: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Germany: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: France: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: France: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: United Kingdom: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: United Kingdom: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Italy: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 87: Italy: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 88: Spain: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 89: Spain: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 90: Russia: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 91: Russia: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 92: Others: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 93: Others: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 94: Latin America: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 95: Latin America: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 96: Brazil: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 97: Brazil: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 98: Mexico: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 99: Mexico: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 100: Others: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 101: Others: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 102: Middle East and Africa: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 103: Middle East and Africa: Cancer Biomarkers Market: Breakup by Country (in %), 2022
Figure 104: Middle East and Africa: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 105: Global: Cancer Biomarkers Industry: SWOT Analysis
Figure 106: Global: Cancer Biomarkers Industry: Value Chain Analysis
Figure 107: Global: Cancer Biomarkers Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Cancer Biomarkers Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Cancer Biomarkers Market Forecast: Breakup by Profiling Technology (in Million US$), 2023-2028
Table 3: Global: Cancer Biomarkers Market Forecast: Breakup by Biomolecule (in Million US$), 2023-2028
Table 4: Global: Cancer Biomarkers Market Forecast: Breakup by Cancer Type (in Million US$), 2023-2028
Table 5: Global: Cancer Biomarkers Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 6: Global: Cancer Biomarkers Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 7: Global: Cancer Biomarkers Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 8: Global: Cancer Biomarkers Market: Competitive Structure
Table 9: Global: Cancer Biomarkers Market: Key Players

02-2729-4219

+886-2-2729-4219